Exhibitors Search
korea techno-venture Co., Ltd.
Booth no.
E42
|
Exhibition
|
|KOREA LIFE SCIENCE |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|28 Seolleung-ro 92-gil, Gangnam-gu, Seoul, Republic of Korea |
|
Tel
|
|+82-2-404-0693 |
|
Exhibits
|
| Nose-to-Brain Drug Delivery Formulation Technologies/Novel Drug Delivery System |
|
Company Type
|
| Biotech Venture / Startup , Technology Transfer / Licensing Organization , etc(대일본 시장진출지원, 일본기술도입 지원) |
Exhibitor Information
Korea Techno-Venture Co., Ltd. was established to carry on and further develop the Korea?Japan business exchange and cooperation activities formerly undertaken by the Korea Technology Venture Foundation, with the goal of becoming a specialized company dedicated to supporting global business commercialization.
The members of Korea Technology Venture Co., Ltd. have 24 years of experience supporting the global commercialization of startups, from the establishment of the Korea Technology Venture Foundation in 2001 until its dissolution in April 2025. In addition, since the establishment of the Foundation’s Tokyo Office in 2003, our team has accumulated more than 20 years of experience in supporting technology commercialization and business cooperation between Korea and Japan.
At this exhibition, we aim to introduce Japanese companies, deepen business exchanges between Korea and Japan, and strengthen engagement with Korean startups seeking to enter the Japanese market.
The members of Korea Technology Venture Co., Ltd. have 24 years of experience supporting the global commercialization of startups, from the establishment of the Korea Technology Venture Foundation in 2001 until its dissolution in April 2025. In addition, since the establishment of the Foundation’s Tokyo Office in 2003, our team has accumulated more than 20 years of experience in supporting technology commercialization and business cooperation between Korea and Japan.
At this exhibition, we aim to introduce Japanese companies, deepen business exchanges between Korea and Japan, and strengthen engagement with Korean startups seeking to enter the Japanese market.
Exhibit Description
1. New Treatment Options for Brain Disorders through Drug Delivery to the Brain
Intranasal Drug Delivery System (DDS) Formulation Technology
Key Technologies: Formulation processing and formulation design technologies (drug development platform technology)
Preferred Forms of Collaboration: Investment, joint research, MTA (Material Transfer Agreement), and MOU
2. Ultra-Low-Dose Local Drug Delivery Device to Reduce Side Effects in Cancer Treatment
Core Technology: Electroosmotic flow pump that converts electrical energy into fluid flow
Patented Technologies:
Portable compact drug infusion device
Drug delivery unit
Drug delivery device and drug management system
Preferred Forms of Collaboration: Investment, joint research, manufacturing partnerships, and sales/distribution partnerships
Intranasal Drug Delivery System (DDS) Formulation Technology
Key Technologies: Formulation processing and formulation design technologies (drug development platform technology)
Preferred Forms of Collaboration: Investment, joint research, MTA (Material Transfer Agreement), and MOU
2. Ultra-Low-Dose Local Drug Delivery Device to Reduce Side Effects in Cancer Treatment
Core Technology: Electroosmotic flow pump that converts electrical energy into fluid flow
Patented Technologies:
Portable compact drug infusion device
Drug delivery unit
Drug delivery device and drug management system
Preferred Forms of Collaboration: Investment, joint research, manufacturing partnerships, and sales/distribution partnerships
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : Intranasal Formulation Technology for Drug Delivery to the Brain / Ultra-Low-Dose Local Drug Delivery Device for Cancer Treatment with Minimal Side Ef1. New Treatment Options for Brain Disorders through Drug Delivery to the Brain Intranasal Drug Delivery System (DDS) Formulation Technology Key Technologies: Formulation processing and formulation design technologies (drug development platform technology) Preferred Forms of Collaboration: Investment, joint research, MTA (Material Transfer Agreement), and MOU 2. Ultra-Low-Dose Local Drug Delivery Device to Reduce Side Effects in Cancer Treatment Core Technology: Electroosmotic flow pump that converts electrical energy into fluid flow Patented Technologies: Portable compact drug infusion device Drug delivery unit Drug delivery device and drug management system Preferred Forms of Collaboration: Investment, joint research, manufacturing partnerships, and sales/distribution partnerships
Co-Exhibitor or
Partner’s Information
|
MORPHEUS Co., Ltd.
|
|
campuscreate co., ltd.
|
|
smilecurve co., ltd.
|
|
accelstars co., ltd.
|
|
mycogenome co., ltd.
|
KYUNGYON EXHIBITION CORP.
